AMC Scene

We suggest that you check your maps and prepare a trail of breadcrumbs, because we are heading back into the labyrinth for Wes Ball's MAZE RUNNER: THE DEATH CURE . Continuing to buck the trend of Young Adult obsession, the concluding chapter of the movie series rounds off James Dashner's book saga of the same name. Starting in 2014, the first MAZE RUNNER film starred the likes of Dylan O'Brien, Will Poulter, Patricia Clarkson, and Kaya Scodelario. Continuing in 2015 with THE SCORCH TRIALS, Ball ends his trilogy with the threequel. After some major setbacks on the set, MAZE RUNNER: THE DEATH CURE is finally here to make us feel so much better. What's At The Middle Of The Maze? While some YA franchises like MORTAL INSTRUMENTS and DIVERGENT always seemed destined for an early grave, the likes of TWILIGHT and THE HUNGER GAAMES cashed in on the romance and revelations that continue to pull us to cinemas in droves. It is no surprise that 20th Century Fox has opted for a rather Hunger Games-esque vibe for the MAZE RUNNER finale. The movie was delayed by over a year, but fans of the MAZE RUNNER franchise will be relieved to see the world of the Gladers in theaters once again. The stakes are raised as the kids continue to take on the oppressive regime of the World in Catastrophe: Killzone Experiment Department (WCKD). O'Brien returns as the tenacious Thomas, who is morbidly reminded in the trailer that "you can't save everyone." Thankfully, the 26-year-old was saved from a near-death experience when filming MAZE RUNNER: THE DEATH CURE in early 2016. Thankfully, after some recuperation, the Teen Wolf star returned to complete MAZE RUNNER: THE DEATH CURE. The final film sees the surviving team of intrepid teens going back to the start of it all, breaking into a WCKD-controlled death trap of twists and turns known as the Last City. Picking up where SCORCH TRIALS left off, Thomas and co. are still reeling from their betrayal at the hands of Scodelario's Teresa, so expect there to be some strained relationships in Part 3. While trying to rescue their friends from the clutches of the evil organization, the group must also battle with their newfound knowledge of a deadly disease called the Flare. Saving those you love or rescuing humanity from sure annihilation seems to be the order of the day, but will anyone make it to the credits alive? MAZE RUNNER: THE DEATH CURE appears set to have more danger than ever before, and also boasts an impressive high-speed train setpiece. We're curious about returning characters, too. Notice that the trailer also features old footage of Game of Thrones star Aidan Gillen as Janson from Scorch Trials . Although Gillen is clearly spotted in the trailer, IMDb doesn't feature him on MAZE RUNNER: THE DEATH CURE's cast list and it is currently unknown whether the actor will reprise his role for the final installment. Either way, there is plenty of A-list talent to close the book on the MAZE RUNNER movies, and MAZE RUNNER: THE DEATH CURE looks to be an action-packed swansong to the series when it hits cinemas on January 26.

AMC Scene

The Maze Runner trilogy will conclude when the highly-anticipated Maze Runner: The Death Cure hits theaters on January 26. Fans have been anxious to see the franchise's final installment, which was delayed for almost a year after the film's star, Dylan O’Brien, sustained serious injuries while filming. Now that the film is finally on its way, fans have set social media on fire in anticipation. According to Variety, Maze Runner: The Death Cure sparked nearly 600,000 new conversations in the final week of December, beating out The Incredibles 2 and Fifty Shades Freed . This is no small task, but what does it mean for the movie? For one, it means people are excited about the film. More importantly, it speaks to the popularity of young adult (YA) films in general. Over the past decade, the Twilight and Hunger Games franchises have dominated at the box office, but as other contenders failed, many believed the genre had fizzled out. Now, given the high interest in Maze Runner: The Death Cure , it's possible the movie might breathe new life into the YA genre. It might sound odd to hear that the final film in a franchise could save a whole genre, but it’s true. It’s more about the entire Maze Runner franchise, but the buzz surrounding The Death Cure is a huge part of the equation. A large reason the YA genre started to fail was because studios were spending too much on films that weren’t received well. The Divergent series is a prime example, and to many was the last vestige of the large YA blockbusters. Lionsgate lost a lot of money on the Divergent films, and the series was concluded prematurely as a result. On the other hand, the Maze Runner franchise has proven that YA films can be made on a conservative budget and still bring in audiences. The first Maze Runner film surprised everyone, and with a relatively small budget of $30 million, was a financial success for Fox. It wasn’t a box office juggernaut like the Twilight or Hunger Games films, but it didn't have to be. The movie grossed over $300 million worldwide. The second film, Maze Runner: The Scorch Trials , followed suit and made over $300 million on a $60 million budget. To date, the franchise has grossed over $600 million on a combined $90 million production budget. In many ways, the Maze Runner franchise has redefined how the public perceives YA movies. Sure, it’s a film about teens in a dystopian future, but unlike its YA predecessors, it’s not a giant tentpole film. These are fun movies with medium budgets that prioritize appealing casts, and they don’t have to break box office records to succeed. Sadly, the delay between The Scorch Trials and The Death Cure caused some audiences to forget about the franchise, but that will soon be remedied. If Maze Runner: The Death Cure can outperform (or match) the two previous films, it could cause other studios to look at what Fox accomplished. If we learned anything from Hollywood, it’s that success breeds competition. It’s very likely that the success of Maze Runner: The Death Cure could lead to more YA titles being adopted by other studios. (Disney already has the high-profile adaptation of A Wrinkle In Time ready to release, which could build on Maze Runner success.) Given the social media buzz surrounding The Death Cure , it looks like the film it’s on its way to success. Reviews for the film have not been revealed yet, but if The Death Cure can garner relatively positive reviews, it should do very well. It also helps that the movie has no competition at the box office in its first weekend. In fact, the final Maze Runner film has a full 2 weeks to rake in money before Marvel Studio’s Black Panther is released. It’s not a sure thing, but given the Maze Runner franchise's track record, The Death Cure has a great chance at success. Only time will tell if the film can refresh the YA landscape, but for now the final Maze Runner film looks like the genre’s best hope. Make sure you catch Maze Runner: The Death Cure when it hits theaters on January 26, 2018. (Source: Variety )

AMC Scene

A movie franchise is a commitment. Even with the promise of greater fame, job security, and, hopefully, a hefty paycheck, agreeing to become the face of a franchise is no small thing. With most studio franchises operating on an every-other-year schedule, once an actor signs on the dotted line, they are, for all intents and purposes, signing their life over to that franchise for the next half decade at the very least. First there's prepping for the shoot, then the shoot itself, and then a long promotional tour. Beyond that, the promotion never really ends in today's era of movies being closely followed from the green light right up to release. For an actor, the franchise becomes a constant part of their life. Which is why Dylan O'Brien's commitment to completing the MAZE RUNNER trilogy is so impressive. Even the most normal production can stretch one's resolve. The production of THE DEATH CURE, the third and final movie in the MAZE RUNNER series, however, was anything but normal. Almost two years ago, in March of 2016, then 24-year-old O'Brien was on the DEATH CURE set, ready to tackle the last movie. They were just days into filming when a stunt involving a car went horribly wrong and the young actor was run over. It was reported that he had suffered severe injuries and multiple broken bones, and had been rushed to the hospital. The accident was serious enough that production shut down while he recovered. At the time, it was assumed that the shut down would last no more than a few weeks, a month at most. When the shutdown stretched into weeks, and then months, rumors began to fly. It was speculated that O'Brien would be recast or even that the final movie might be scrapped completely. The actor largely kept himself out of the spotlight in the months after and his family, friends, and everyone involved with the production refused to divulge details for reasons both personal and likely legal. Production finally resumed a full year later with O'Brien still in the lead, but it left everyone wondering what had really happened in the year between filming shutting down and resuming. It wasn't until September of last year that O'Brien felt he was in a stable enough place to publicly talk about the accident with Vulture and explain what he went through during recovery. In truth, his injuries had been far worse than we knew. Half a year into his long and arduous recovery he was in such a dark place that he wondered if he'd ever return to acting at all. Both physically and mentally, he was at the lowest place he'd ever been, and with just five short career years under his belt, he was seriously questioning whether or not he'd ever be able to get in front of a camera again. Make no mistake, it was not him simply being shaken by a few broken bones. To this day, he still will not speak in detail of the accident, but even so, he's revealed that he suffered a concussion, facial fractures, and brain trauma, among other injuries. Those aren't the kind of injuries that just set a person back a few months; those are the kind of injuries that can reshape the rest of a person's life. And so it was for O'Brien, who found he'd lost a lot of function in his daily life, not just physically, but also emotionally and mentally. In recent years, professional athletes have started opening up about potentially career-ending injuries, particularly the effects of brain trauma and severe concussions. It's not pretty. The extent of the effects of head trauma on athletes is only just starting to be understood by doctors, but what is known is that the psychological toll is greater than we ever realized, often continuing to affect the athlete long after the physical injury has healed. Acting isn't a profession where the threat of serious injury is less a potential than a promise, but Dylan O'Brien's injuries had the same lasting effects on the young actor. Even when he finally got back to work months later, not on THE DEATH CURE, but AMERICAN ASSASSIN, a project to which he'd been signed before his injury, he was mostly faking it. Before filming even began, O'Brien had to commit to a regular gym routine to get in shape for the role. Gym sessions with his personal trainer would regularly be put on hold when he had a panic attack upon arriving at the gym and would be unable to get through a session. When the day came to board his flight to London to begin filming, O'Brien had one of the worst breakdowns he'd ever experienced, to the point he wasn't sure he'd be able to get on the plane. With the support of his family and close friends, he persevered and finished shooting for AMERICAN ASSASSIN. Still, the hardest challenge yet was looming: returning to the set of THE MAZE RUNNER, the place where everything had come undone. It's difficult to imagine how daunting it must have been. Trauma leaves scars. A restaurant you can no longer go because it carries painful memories of a failed relationship in happier times; a song that presses painfully on an old heartbreak; a sentimental memento that hits you with the unexpected grief of a loved one lost. Now imagine having to face returning to a place where you'd come very close to dying less than a year before. It would have been understandable if he had walked away. It's a testament to O'Brien's mental fortitude and courage that he didn't. He had committed to the role and he was determined to finish it. Filming resumed in March 2017 in South Africa and wrapped in June. Now, seeing O'Brien giving countless interviews to promote the release of MAZE RUNNER: THE DEATH CURE, he's a little more serious, a little less goofy than before his accident. Yet you'd be hard pressed to believe he's the same guy who, less than a year and a half ago, was wondering if he'd be able to get in front of a camera ever again. Watching him talk about his passion for the project makes one thing certain: Whether or not THE DEATH CURE is a box office success, Dylan O'Brien deserves our love for being so committed to finishing what he started. MAZE RUNNER: THE DEATH CURE is in theaters on January 26.

Ryan Beckman, a 20-year-old college student from a declining town in the northeast, struggles with a debilitating anxiety disorder following his father's death. Ryan lives with his mother, Renee, and spends his days apprenticing at a local tattoo shop and looking after his younger brother, James. When Ryan’s older brother, Jason, unexpectedly returns home from college, mid-semester, it’s clear that Ryan isn’t the only one battling demons. A mysterious entity begins stalking Ryan, and he is forced to confront the dark presence before it destroys what remains of his family.

We suggest that you check your maps and prepare a trail of breadcrumbs, because we are heading back into the labyrinth for Wes Ball's MAZE RUNNER: THE DEATH CURE . Continuing to buck the trend of Young Adult obsession, the concluding chapter of the movie series rounds off James Dashner's book saga of the same name. Starting in 2014, the first MAZE RUNNER film starred the likes of Dylan O'Brien, Will Poulter, Patricia Clarkson, and Kaya Scodelario. Continuing in 2015 with THE SCORCH TRIALS, Ball ends his trilogy with the threequel. After some major setbacks on the set, MAZE RUNNER: THE DEATH CURE is finally here to make us feel so much better. What's At The Middle Of The Maze? While some YA franchises like MORTAL INSTRUMENTS and DIVERGENT always seemed destined for an early grave, the likes of TWILIGHT and THE HUNGER GAAMES cashed in on the romance and revelations that continue to pull us to cinemas in droves. It is no surprise that 20th Century Fox has opted for a rather Hunger Games-esque vibe for the MAZE RUNNER finale. The movie was delayed by over a year, but fans of the MAZE RUNNER franchise will be relieved to see the world of the Gladers in theaters once again. The stakes are raised as the kids continue to take on the oppressive regime of the World in Catastrophe: Killzone Experiment Department (WCKD). O'Brien returns as the tenacious Thomas, who is morbidly reminded in the trailer that "you can't save everyone." Thankfully, the 26-year-old was saved from a near-death experience when filming MAZE RUNNER: THE DEATH CURE in early 2016. Thankfully, after some recuperation, the Teen Wolf star returned to complete MAZE RUNNER: THE DEATH CURE. The final film sees the surviving team of intrepid teens going back to the start of it all, breaking into a WCKD-controlled death trap of twists and turns known as the Last City. Picking up where SCORCH TRIALS left off, Thomas and co. are still reeling from their betrayal at the hands of Scodelario's Teresa, so expect there to be some strained relationships in Part 3. While trying to rescue their friends from the clutches of the evil organization, the group must also battle with their newfound knowledge of a deadly disease called the Flare. Saving those you love or rescuing humanity from sure annihilation seems to be the order of the day, but will anyone make it to the credits alive? MAZE RUNNER: THE DEATH CURE appears set to have more danger than ever before, and also boasts an impressive high-speed train setpiece. We're curious about returning characters, too. Notice that the trailer also features old footage of Game of Thrones star Aidan Gillen as Janson from Scorch Trials . Although Gillen is clearly spotted in the trailer, IMDb doesn't feature him on MAZE RUNNER: THE DEATH CURE's cast list and it is currently unknown whether the actor will reprise his role for the final installment. Either way, there is plenty of A-list talent to close the book on the MAZE RUNNER movies, and MAZE RUNNER: THE DEATH CURE looks to be an action-packed swansong to the series when it hits cinemas on January 26.

The Maze Runner trilogy will conclude when the highly-anticipated Maze Runner: The Death Cure hits theaters on January 26. Fans have been anxious to see the franchise's final installment, which was delayed for almost a year after the film's star, Dylan O’Brien, sustained serious injuries while filming. Now that the film is finally on its way, fans have set social media on fire in anticipation. According to Variety, Maze Runner: The Death Cure sparked nearly 600,000 new conversations in the final week of December, beating out The Incredibles 2 and Fifty Shades Freed . This is no small task, but what does it mean for the movie? For one, it means people are excited about the film. More importantly, it speaks to the popularity of young adult (YA) films in general. Over the past decade, the Twilight and Hunger Games franchises have dominated at the box office, but as other contenders failed, many believed the genre had fizzled out. Now, given the high interest in Maze Runner: The Death Cure , it's possible the movie might breathe new life into the YA genre. It might sound odd to hear that the final film in a franchise could save a whole genre, but it’s true. It’s more about the entire Maze Runner franchise, but the buzz surrounding The Death Cure is a huge part of the equation. A large reason the YA genre started to fail was because studios were spending too much on films that weren’t received well. The Divergent series is a prime example, and to many was the last vestige of the large YA blockbusters. Lionsgate lost a lot of money on the Divergent films, and the series was concluded prematurely as a result. On the other hand, the Maze Runner franchise has proven that YA films can be made on a conservative budget and still bring in audiences. The first Maze Runner film surprised everyone, and with a relatively small budget of $30 million, was a financial success for Fox. It wasn’t a box office juggernaut like the Twilight or Hunger Games films, but it didn't have to be. The movie grossed over $300 million worldwide. The second film, Maze Runner: The Scorch Trials , followed suit and made over $300 million on a $60 million budget. To date, the franchise has grossed over $600 million on a combined $90 million production budget. In many ways, the Maze Runner franchise has redefined how the public perceives YA movies. Sure, it’s a film about teens in a dystopian future, but unlike its YA predecessors, it’s not a giant tentpole film. These are fun movies with medium budgets that prioritize appealing casts, and they don’t have to break box office records to succeed. Sadly, the delay between The Scorch Trials and The Death Cure caused some audiences to forget about the franchise, but that will soon be remedied. If Maze Runner: The Death Cure can outperform (or match) the two previous films, it could cause other studios to look at what Fox accomplished. If we learned anything from Hollywood, it’s that success breeds competition. It’s very likely that the success of Maze Runner: The Death Cure could lead to more YA titles being adopted by other studios. (Disney already has the high-profile adaptation of A Wrinkle In Time ready to release, which could build on Maze Runner success.) Given the social media buzz surrounding The Death Cure , it looks like the film it’s on its way to success. Reviews for the film have not been revealed yet, but if The Death Cure can garner relatively positive reviews, it should do very well. It also helps that the movie has no competition at the box office in its first weekend. In fact, the final Maze Runner film has a full 2 weeks to rake in money before Marvel Studio’s Black Panther is released. It’s not a sure thing, but given the Maze Runner franchise's track record, The Death Cure has a great chance at success. Only time will tell if the film can refresh the YA landscape, but for now the final Maze Runner film looks like the genre’s best hope. Make sure you catch Maze Runner: The Death Cure when it hits theaters on January 26, 2018. (Source: Variety )

Ryan Beckman, a 20-year-old college student from a declining town in the northeast, struggles with a debilitating anxiety disorder following his father's death. Ryan lives with his mother, Renee, and spends his days apprenticing at a local tattoo shop and looking after his younger brother, James. When Ryan’s older brother, Jason, unexpectedly returns home from college, mid-semester, it’s clear that Ryan isn’t the only one battling demons. A mysterious entity begins stalking Ryan, and he is forced to confront the dark presence before it destroys what remains of his family.

Blumhouse (SPLIT, GET OUT, PARANORMAL ACTIVITY series) produces an original and inventive rewinding thriller in HAPPY DEATH DAY, in which a college student (Jessica Rothe, LA LA LAND) relives the day of her murder with both its unexceptional details and terrifying end until she discovers her killer's identity. HAPPY DEATH DAY is directed by Christopher Landon (PARANORMAL ACTIVITY: THE MARKED ONES).

The story of Christopher Reeve is an astonishing rise from unknown actor to iconic movie star, and his definitive portrayal of Clark Kent/Superman set the benchmark for the superhero cinematic universes that dominate cinema today. Reeve portrayed the Man of Steel in four Superman films and played dozens of other roles that displayed his talent and range as an actor, before being injured in a near-fatal horse-riding accident in 1995 that left him paralyzed from the neck down. After becoming a quadriplegic, he became a charismatic leader and activist in the quest to find a cure for spinal cord injuries, as well as a passionate advocate for disability rights and care - all while continuing his career in cinema in front of and behind the camera and dedicating himself to his beloved family. From the directors of McQueen, Ian Bonhote and Peter Ettedgui, this film includes never-before-seen intimate home movies and an extraordinary trove of personal archive material, as well as the first extended interviews ever filmed with Reeve’s three children about their father, and interviews with the A-list Hollywood actors who were Reeve’s colleagues and friends. The film is a moving and vivid cinematic telling of Reeve’s remarkable story.